Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3001
-0.0060 (-1.96%)
At close: May 30, 2025, 4:00 PM
0.3000
-0.0001 (-0.03%)
After-hours: May 30, 2025, 6:58 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $17.77 million as of May 30, 2025. Its market cap has decreased by -90.86% in one year.
Market Cap
17.77M
Enterprise Value
-31.63M
1-Year Change
-90.86%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $17.77M, a decrease of -95.13%. That is a compound annual growth rate of -53.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 17.77M | -46.56% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.13B |
| Johnson & Johnson | 373.40B |
| AbbVie | 328.59B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.07B |
| Abbott Laboratories | 232.70B |
| AstraZeneca | 224.00B |
| Novartis AG | 219.70B |